ZAVESCA is a prescription medicine primarily used to treat a specific condition in adults.
ZAVESCA's Primary Use
ZAVESCA (miglustat) is a prescription medication used alone to treat adults with mild to moderate type 1 Gaucher disease. According to the prescribing information, it is specifically indicated for individuals who cannot be treated with enzyme replacement therapy.
Important Considerations:
- Adult Use: ZAVESCA is approved for use in adults.
- Gaucher Disease: It specifically targets type 1 Gaucher disease.
- Alternative Therapy: It serves as an alternative for those unsuitable for enzyme replacement therapy.
- Pediatric Use: The safety and effectiveness of ZAVESCA in children under 18 years of age have not been established.
In summary, ZAVESCA offers a treatment option for adults with mild to moderate type 1 Gaucher disease, particularly when enzyme replacement therapy is not a viable option.
